Citations: Garthwaite, Craig. 2012. The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors. American Economic Journal: Applied Economics. (3)116-137.

Senior management must recognize that resources have to be applied to nurture ... Overall, in our view, open innovation is a valuable model for large pharmaceutical companies.

Dr Sanjay Agrawal, a renowned pharmaceutical consultant and scientific advisor of Alkomex GBN Pharma Group USA, has recently applied for a patent for an anti-aging formulation. Dr Agrawal has ...